BackgroundCheck.run
Search For

Daniel V Santi, 821382 Leggs Ln, Schellville, CA 95476

Daniel Santi Phones & Addresses

1382 Leggs Ln, Sonoma, CA 95476    707-9353676   

211 Belgrave Ave, San Francisco, CA 94117    415-6655775    707-9353676   

Hayward, CA   

Burlingame, CA   

Education

School / High School: University of California At San Francisco 1981

Languages

English

Mentions for Daniel V Santi

Career records & work history

Medicine Doctors

Daniel Santi Photo 1

Dr. Daniel V Santi, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Anatomic & Clinical Pathology
Address:
211 Belgrave Ave, San Francisco, CA 94117
415-5335775 (Phone)
Languages:
English
Education:
Medical School
University of California At San Francisco
Graduated: 1981

Daniel Santi resumes & CV records

Resumes

Daniel Santi Photo 32

Owner And President

Work:
Diplomat Renovations
Owner and President
Daniel Santi Photo 33

President

Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Prolynx
President
Ucsf Medical Center
Assoc Dean, Sop
Ucsf Medical Center
Professor
Education:
State University of New York College at Buffalo
Doctorates, Doctor of Philosophy, Philosophy
University of California, San Francisco
Doctor of Medicine, Doctorates, Medicine
Skills:
Design
Daniel Santi Photo 34

Daniel Santi

Daniel Santi Photo 35

Daniel Santi

Daniel Santi Photo 36

Daniel Santi

Publications & IP owners

Us Patents

Multi-Plasmid Method For Preparing Large Libraries Of Polyketides And Non-Ribosomal Peptides

US Patent:
6399789, Jun 4, 2002
Filed:
Apr 12, 2000
Appl. No.:
09/548060
Inventors:
Daniel V. Santi - San Francisco CA
Qun Xue - San Francisco CA
Gary Ashley - Alameda CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D31316
US Classification:
549271, 536 41
Abstract:
A multiple-plasmid system for heterologous expression of polyketides facilitates combinatorial biosynthesis. The method can be extended to any modular polyketide synthase (PKS) or non-ribosomal peptide synthase (NRPS) and has the potential to produce thousands of novel natural products, including ones derived from further modification of the PKS or NRPS products by tailoring enzymes.

Isolated Nucleic Acids Relating To The Fkba Gene Within The Fk-520 Polyketide Synthase Gene Cluster

US Patent:
6503737, Jan 7, 2003
Filed:
Oct 1, 1999
Appl. No.:
09/410551
Inventors:
Christopher Reeves - Orinda CA
Daniel Chu - Santa Clara CA
Chaitan Khosla - Palo Alto CA
Daniel Santi - San Francisco CA
Kai Wu - Foster City CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C12P 1962
US Classification:
435 76, 4353201, 4352523, 43525235, 536 231, 536 232
Abstract:
Host cells comprising recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide. Recombinant DNA constructs comprising one or more FK-520 polyketide synthase domains, modules, open reading frames, and variants thereof can be used to produce recombinant polyketide synthases and a variety of different polyketides with application as pharmaceutical and veterinary products.

Motilide Compounds

US Patent:
6562795, May 13, 2003
Filed:
Feb 15, 2001
Appl. No.:
09/788314
Inventors:
Gary Ashley - Alameda CA
Mark Burlingame - San Francisco CA
Christopher Carreras - Belmont CA
Daniel Santi - San Francisco CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
A61K 3170
US Classification:
514 29, 536 72, 536 74
Abstract:
The present invention provides novel macrolide compounds of the formulas wherein: R is hydroxyl or methoxy; R is selected from the group consisting of hydrogen, hydroxyl, halide, NH , OR , âwhere R is C -C alkyl, C -C alkenyl, C -C alkynyl, aryl or heteroaryl and R and R are each independently hydrogen, C -C alkyl, C -C alkenyl, C -C alkynyl, or aryl; R and R are each independently selected from the group consisting of hydrogen, C -C alkyl, C -C alkenyl, C -C alkynyl, aryl, alkylaryl, alkenylaryl, alkynylaryl or R and R together form a cycloalkyl or a cycloaryl moiety; R is hydrogen or methyl; R is hydrogen, hydroxyl, oxo, or together with R and the carbons to which they are attached form a cyclic carbonate; R is hydrogen, hydroxyl, OR where R is C -C alkyl, C -C alkenyl, C -C alkynyl, or together with R and the carbons to which they are attached form a cyclic carbonate; R is methyl, C -C alkyl, C -C alkenyl, C -C alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; R is C -C alkyl, C -C alkenyl, C -C alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; and, x is a single or a double bond.

Polyketide Derivatives

US Patent:
6569867, May 27, 2003
Filed:
May 10, 2001
Appl. No.:
09/853306
Inventors:
Daniel Chu - Santa Clara CA
Maria Fardis - San Carlos CA
Chaitan Khosla - Palo Alto CA
Christopher Reeves - Orinda CA
Daniel Santi - San Francisco CA
Andreas Schirmer - Hayward CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D49816
US Classification:
514291, 540456
Abstract:
The present invention relates to novel polyketides, host cells that produce the novel compounds, and methods fort their use. The compounds of the present invention are cyclic polyketides (also referred to as a âmacrolidesâ or âmacrolactonesâ) that include as part of their structure and bind to a FK binding protein wherein R and R are each selected from the group consisting of hydrogen, methyl, ethyl, and methoxy, provided that at least one of R and R is hydrogen, methyl, or ethyl. As will be explained in greater detail below, the compounds of the present invention have properties such as favorable P450 enzyme activity profiles that are desirable for use of these compounds as drugs.

Polyketide Derivatives

US Patent:
6624302, Sep 23, 2003
Filed:
Dec 27, 2002
Appl. No.:
10/331047
Inventors:
Daniel Chu - Santa Clara CA
Maria Fardis - San Carlos CA
Chaitan Khosla - Palo Alto CA
Christopher Reeves - Orinda CA
Daniel Santi - San Francisco CA
Andreas Schirmer - Hayward CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D49816
US Classification:
540456
Abstract:
The present invention relates to novel polyketides, host cells that produce the novel compounds, and methods fort their use. The compounds of the present invention are cyclic polyketides (also referred to as a âmacrolidesâ or âmacrolactonesâ) that include as part of their structure and bind to a FK binding protein wherein R and R are each selected from the group consisting of hydrogen, methyl, ethyl, and methoxy, provided that at least one of R and R is hydrogen, methyl, or ethyl. As will be explained in greater detail below, the compounds of the present invention have properties such as favorable P450 enzyme activity profiles that are desirable for use of these compounds as drugs.

Polyketide Synthase Enzymes And Recombinant Dna Constructs Therefor

US Patent:
6660862, Dec 9, 2003
Filed:
Apr 3, 2001
Appl. No.:
09/825621
Inventors:
Christopher Reeves - Orinda CA
Daniel Chu - Santa Clara CA
Chaitan Khosla - Palo Alto CA
Daniel Santi - San Francisco CA
Kai Wu - Foster City CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D51500
US Classification:
546 92
Abstract:
Polyketide compounds of the formula but not including FK-506, FK-520, 18-hydroxy-FK520 and 18-hydroxy-FK-506.

Motilide Compounds

US Patent:
6750205, Jun 15, 2004
Filed:
Apr 7, 2003
Appl. No.:
10/409429
Inventors:
Gary Ashley - Alameda CA
Mark Burlingame - San Francisco CA
Christopher Carreras - Belmont CA
Daniel Santi - San Francisco CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
A61K 3170
US Classification:
514 29, 536 72, 536 74
Abstract:
The present invention provides novel macrolide compounds of the formulas wherein: R is hydroxyl or methoxy; R is selected from the group consisting of hydrogen, hydroxyl, halide, NH , OR , where R is C -C alkyl, C -C alkenyl, C -C alkynyl, aryl or heteroaryl and R and R are each independently hydrogen, C -C alkyl, C -C alkenyl, C -C alkynyl, or aryl; R and R are each independently selected from the group consisting of hydrogen, C -C alkyl, C -C alkenyl, C -C alkynyl, aryl, alkylaryl, alkenylaryl alkynylaryl or R and R together form a cycloalkyl or a cycloaryl moiety; R is hydrogen or methyl; R is hydrogen, hydroxyl, oxo, or together with R and the carbons to which they are attached form a cyclic carbonate; R is hydrogen, hydroxyl, OR where R is C -C alkyl, C -C alkenyl, C -C alkynyl, or together with R and the carbons to which they are attached form a cyclic carbonate; R is methyl, C -C alkyl, C -C alkenyl, C -C alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; R is C -C alkyl, C -C alkenyl, C -C alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; and, x is a single or a double bond.

Polynucleotides Encoding The Fkba Gene Of The Fk-520 Polyketide Synthase Gene Cluster

US Patent:
6759536, Jul 6, 2004
Filed:
Aug 27, 2001
Appl. No.:
09/940316
Inventors:
Christopher Reeves - Orinda CA
Daniel Chu - Santa Clara CA
Chaitan Khosla - Palo Alto CA
Daniel Santi - San Francisco CA
Kai Wu - Foster City CA
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C07D22118
US Classification:
546 71
Abstract:
Host cells comprising recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide. Recombinant DNA constructs comprising one or more FK-520 polyketide synthase domains, modules, open reading frames, and variants thereof can be used to produce recombinant polyketide synthases and a variety of different polyketides with application as pharmaceutical and veterinary products.

Public records

Vehicle Records

Daniel Santi

Address:
211 Belgrave Ave, San Francisco, CA 94117
Phone:
415-6655775
VIN:
WBAWB73547P034087
Make:
BMW
Model:
3 SERIES
Year:
2007

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.